Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

John W. Ostrominski(Brigham and Women's Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital), Brian Claggett(National Heart Lung and Blood Institute), Anna Maria Langkilde(AstraZeneca (Sweden)), Adrian F. Hernandez(Duke University), Pardeep S. Jhund(Copenhagen University Hospital), John J.V. McMurray(University of Glasgow), Rudolf A. de Boer(Erasmus MC), Felipe A. Martínez(Universidad Nacional de Córdoba), Mikhail Kosiborod(AstraZeneca (Brazil)), Scott D. Solomon(Brigham and Women's Hospital), Jorge Thierer(Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno), Carolyn S.P. Lam(University of Glasgow), Magnus Petersson(Sahlgrenska University Hospital), Zi Michael Miao(Brigham and Women's Hospital), Silvio E. Inzucchi(Yale University), Akshay S. Desai(Brigham and Women's Hospital), Sanjiv J. Shah(Northwestern University)
JACC Heart Failure
May 24, 2023
Cited by 39


Related Papers